Efficacy and safety of lenvatinib monotreatment and lenvatinib-based combination therapy for patients with unresectable hepatocellular carcinoma: a retrospective, real-world study in China

BACKGROUND: Lenvatinib and lenvatinib-based combination treatments are widely used in patients with unresectable hepatocellular carcinoma (uHCC) in clinical practice, but their curative effect and safety need further study in the real world. METHODS: This was a retrospective study involving patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yun, Sun, Penghui, Wang, Kunyuan, Xiao, Shuzhe, Cheng, Yanling, Li, Xiangzhao, Wang, Biao, Li, Jiancong, Yu, Wenxuan, Cheng, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449874/
https://www.ncbi.nlm.nih.gov/pubmed/34537075
http://dx.doi.org/10.1186/s12935-021-02200-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449874/
https://www.ncbi.nlm.nih.gov/pubmed/34537075
http://dx.doi.org/10.1186/s12935-021-02200-7

Ejemplares similares